Quantcast Bidirectional Cavopulmonary Shunt -- CTSNet FAQs
Frequently Asked Questions
CTSNet Logo


FAQ

Adult Cardiac Surgery FAQs
General Thoracic Surgery FAQs
Pediatric Cardiac Surgery FAQs

CTSNet Home
 
 
Pediatric Cardiac Surgery FAQs
Section Editor: Tom R. Karl, M.D.


Bidirectional Cavopulmonary Shunt
John A Hawkins

1.
Does the bidirectional cavopulmonary shunt lower the risk of a subsequent Fontan procedure (i.e., performed as a staging procedure) as compared to a Fontan procedure with no previous bidirectional cavopulmonary shunt?
2.
What age is optimal for performance of the bidirectional cavopulmonary shunt?
3.
What is the optimal timing for conversion of a patient with a bidirectional cavopulmonary shunt to a Fontan circulation (total avopulmonary connection)?
4.
Is the bidirectional cavopulmonary shunt best performed with cardiopulmonary bypass or without extracorporeal circulation, utilizing a superior cava to right atrial shunt?
5.
Is the bidirectional cavopulmonary shunt best performed with or without an additional source of pulmonary blood flow (i.e., leaving antegrade flow through a pulmonary artery band or leaving open a systemic pulmonary shunt)?
6.
What is the hemi-Fontan procedure and how does it differ from the bidirectional cavopulmonary shunt?

   

1.

Does the bidirectional cavopulmonary shunt lower the risk of a subsequent Fontan procedure (i.e., performed as a staging procedure) as compared to a Fontan procedure with no previous bidirectional cavopulmonary shunt? 

The overwhelming feeling at present is that the bidirectional cavopulmonary shunt (BCPS) is an excellent staging procedure for the infant with a single functional ventricle and lowers the morbidity and the mortality of a subsequent Fontan procedure. The BCPS reduces the volume overload on the functional single ventricle (when extra sources of pulmonary blood flow are eliminated) and improves the efficiency of the pulmonary circulation and oxygenation. It is felt that this reduction of volume overload will allow regression of ventricular hypertrophy that is thought to contribute to the diastolic dysfunction and morbidity of the Fontan procedure. In addition to this, the BCPS can lower the mean pulmonary artery pressure over time, thereby lowering the risk of a subsequent Fontan procedure. The BCPS can be applied in infants as young as 4-6 weeks of age and often raises the saturation to about 85%. These factors make the BCPS an excellent form of interim palliation in planning the long term strategy for the infant with a single functional ventricle. One possibly detrimental factor of the BCPS is the observation that pulmonary artery growth is often reduced following operation. This may have implications for earlier conversion to a total cavopulmonary connection or Fontan procedure to negate some of the negative effects of the BCPS on pulmonary artery growth. Despite these numerous benefits, there are no randomized trials or hard data or to back up the clinical impression that t he Fontan procedure or fenestrated Fontan procedure actually has a lower mortality rate if preceded by a BCPS.
 

NEXT Question | TOP of Page | FAQs HOME | CTSNet HOME


   

2.

What age is optimal for performance of the bidirectional cavopulmonary shunt? ?

There really is no correct answer. But, the general trend is toward younger application of the BCPS. The BCPS can be performed as young as 3-4 weeks of age, but there are no large series of patients in this age group and very little analysis of late follow-up of patients done at this young age. There is some suggestion that earlier application of the BCPS is associated with an increased formation of arteriovenous fistulae, particularly in infants with heterotaxy syndrome. There is also some evidence that early application of the BCPS is associated with a higher incidence of pulmonary artery thrombosis. Both of these complications are indications of that pulmonary artery resistance is more elevated in younger patients and a slightly higher complication rate may be seen. The currently accepted optimal age for the BCPS is in the 3 to 9 month age range.
 

NEXT Question | TOP of Page | FAQs HOME | CTSNet HOME


   

3.

What is the optimal timing for conversion of a patient with a bidirectional cavopulmonary shunt to a Fontan circulation (total avopulmonary connection)?

Again, there is really no correct answer. However, practical experience tells us that this is usually 12 to 24 months following the BCPS. Several factors are involved in this, but the most prominent is increasing cyanosis that occurs after BCPS, forcing conversion to a total cavopulmonary connection. Cyanosis after BCPS is partially due to the maturational changes seen in infants and small children as the amount of superior caval flow drops in relation to inferior caval venous flow. Late cyanosis is also contributed to by formation of venous collaterals that decompress the superior vena cava into the inferior vena caval system and cause systemic desaturation. In addition, pulmonary artery growth appears to be reduced following the BCPS, particularly after about 15 months following the BCPS. These factors would support conversion of a BCPS in this 12-24 month interval. However, there are distinct disadvantages of the Fontan that are uncommonly seen with the BCPS, such as protein losing enteropathy, late development of supraventricular arrhythmias, and reduction in exercise tolerance. The balancing of these advantages and disadvantages are necessary to determining the optimal timing for conversion of a patient with a BCPS to total cavopulmonary connection or Fontan circulation. An excellent review of this question by Dr. Richard Jonas of Boston Children's Hospital summarizes these concerns (J Thorac Cardiovasc Surg 1994;108:522-524).
 

NEXT Question | TOP of Page | FAQs HOME | CTSNet HOME


   

4.

Is the bidirectional cavopulmonary shunt best performed with cardiopulmonary bypass or without extracorporeal circulation, utilizing a superior cava to right atrial shunt?

Cardiopulmonary bypass does have some detrimental effects on lung water and pulmonary resistance that negatively affect postoperative oxygenation. However, in most instances cardiopulmonary bypass is necessary in order to address coexisting problems that are best dealt with before a Fontan operation, such as pulmonary artery distortion, a restrictive atrial septal defect or subaortic stenosis. Usually the drop in oxygenation following a BCPS done utilizing cardiopulmonary bypass is transient and resolves in 24-48 hours. The BCPS can be performed using a superior vena cava-right atrial shunt and the transient pulmonary dysfunction can be avoided. With the move towards younger patients with more complex problems, the number of patients that c an actually have a BCPS without cardiopulmonary bypass is limited.
 

NEXT Question | TOP of Page | FAQs HOME | CTSNet HOME


   

5.

Is the bidirectional cavopulmonary shunt best performed with or without an additional source of pulmonary blood flow (i.e., leaving antegrade flow through a pulmonary artery band or leaving open a systemic pulmonary shunt)? 

This has been one of the most hotly debated topics in the literature over the last several years. There are advantages and disadvantages of both approaches. Advantages of leaving an extra source of pulmonary blood flow include improved oxygenation and possible prevention of arteriovenous fistulae by preserving perfusion of the pulmonary circulation by a "hepatic factor." Disadvantages include possible detrimental effects of residual volume overload and possible prolongation of postoperative pleural effusions. Since there is no correct answer to this question, the individual surgeon must weigh these advantages and disadvantages for each individual patient and make a decision. If a patient is marginally oxygenated immediately after completion of the BCPS and superior vena caval pressure will allow it, the addition of some flow through a pulmonary artery band or systemic-pulmonary artery shunt may well be advantageous. Conversely, if a patient is adequately oxygenated following a BCPS (saturation >70-75%), then the addition of an extra source of pulmonary blood flow is likely of little benefit.
 

NEXT Question | TOP of Page | FAQs HOME | CTSNet HOME


   

6.

What is the hemi-Fontan procedure and how does it differ from the bidirectional cavopulmonary shunt?

The hemi-Fontan procedure is not, as the name implies, a "half" Fontan procedure. The hemi-Fontan is physiologically equivalent to a BCPS and is simply a method to perform a large connection between the superior vena cava/right atrial junction and the pulmonary artery. The communication between the superior vena cava and lower right atrium is then blocked by a patch, which is later removed when converting to a Fontan-type circulation. Its proponents point out that the Fontan connection is already made and conversion simply involves cutting out this patch and performing an intracardiac tunnel of the IVC to the previously created opening. A possible disadvantage of the hemi-Fontan includes the incision and suture lines across the cavo-atrial junction and the increased possibility of supraventricular arrhythmias, similar to the regular Fontan. The hemi-Fontan also does not allow "offsetting" of the superior and inferior caval blood flow (thereby avoiding "colliding" blood flow pathways) and the resulting theoretical benefits that a number of recent studies have demonstrated inhydraulic fluid flow models of the Fontan procedure. With the recent advent of the extracardiac-tube Fontan, the advantages of the hemi-Fontan have decreased.
 

TOP of Page | CTSNet HOME | FAQs HOME



Additional Pediatric Cardiac Surgery FAQs

* Pediatric Cardiopulmonary Transplantation
* Mechanical Circulatory Support in Children
* Bidirectional Cavopulmonary Shunt
* Hypoplastic Left Heart Syndrome